Aesthetic Medicine Market - Introduction
Aesthetics has become more important in all aspects of everyday life in the past few years. It is the most innovative branch of medicine. The aim of aesthetic medicine is to improve physical appearance and satisfaction of a patient by using minimally invasive or non-invasive procedures. Aesthetic medicine is recommended to healthy individuals who are dissatisfied with some minor deficiencies. Aesthetic medicine is also used to treat conditions such as eczema, allergies, and acne. Moreover, aesthetic treatment includes dermal fillers, microdermabrasion, venous treatment, body countering, cellulite treatment, and chemical peels.
Aesthetic Medicine Market – Competitive Landscape
Key development by market players such as product launch, acquisition and collaboration likely to augment the global market. AGR Medical is a wholesale supplier of aesthetic products offered by Allergan, Galderma Laboratories, and Merz Pharmaceuticals.
Identify the key factors that will drive your company’s growth, Request a brochure of this report here
Founded in 1981, Galderma Laboratories is one of the player operating in the aesthetics market. The company offers the wide range of products for dermatological condition. The company have geographical presence in over 100 countries. The company have partnership with healthcare practitioners to fulfil the skin health needs. Galdema Laboratories have significant research and development to develop solution for hair, nails and skin. Smiths Distributors distributes Galderma Laboratories’ products in more than 100 countries. In December 2018, Galderma Laboratories expanded collaboration with REVISION SKINCARE, ALASTIN Skincare, and SENTÉ skincare brands in the U.S. This enabled the company to offer a range of skincare products along with facial injectable treatments
Incorporated in 1983, headquarter in Dublin, Ireland. Allergen is one of the leading player engaged in developing, manufacturing and commercializing branded pharmaceutical, biological, regenerative and surgical medicine and devices. The company offers the product for eye care, gastroenterology, central nervous system and medical aesthetics. In March 2019, Allergan acquired Envy Medical, Inc. This acquisition enabled the company to strengthen its medical aesthetic product portfolio. Additionally, this enhanced the company’s customer reach.
Established in 1908, headquarter in Frankfurt, Germany. In 1953 the company create first anti - wrinkle moisturizing cream. The company offers the products including botulinum neurotoxin, dermal fillers, revolutionary cellulite treatment, and skin lifting and tightening devices. The company have significant research and development. Merz North America, Inc. distributes Merz’s aesthetic products in 50 states across the U.S. AMP MEDICAL PRODUCTS is global distributor of aesthetic products to aesthetic professionals, large beauty spa retailers, and physicians.
In April 2018, Merz Pharmaceuticals launched Belotero lip dermal filler products. This has enabled physicians to offer unique complementary approach to lip enhancement.
Skin Tech Pharma Group, S.
Skin Tech Pharma Group, S.is a privately held company offers the products for dermatology and gynecology. The company have mainly focused on research and development of new innovative technologies and manufacture a new products.
BIOXIS pharmaceuticals is engaged in developing, manufacturing and commercialization of innovative regenerative medical products. The company offers the products for dermatology and transform aesthetic medicine.
The global aesthetic medicine market is highly fragmented, with presence of large number of leading players. A number of manufacturers hold significant shares in their respective regions.
Expanding operations in future? To get the perfect launch ask for a custom report here
Aesthetic Medicine Market – Dynamics
Inclination towards minimally invasive and non-invasive procedures
Rising number of minimally invasive and noninvasive procedures is factor expected to drive the growth of the segment. For instance, According to the International Society of Aesthetic Plastic Surgery, 4,189,830 facial and head procedures were performed across the globe in 2017. Advancements in topical drug delivery and development of new aesthetic agents such as retinoid, alpha hydroxyl acids and naturally resourced materials is driving key players to introduce new topical aesthetic medicines in the market.
Increase in demand of aesthetic care for skin rejuvenation and skin repair is a latest trend in skin care market. Awareness or socio-economic wellness and demand for aesthetics to treat ageing and other skin related conditions is likely to surge the demand for aesthetic medicines in near future. Rising geriatric population in developed and emerging markets and their demand for anti-wrinkle and skin volume increasing aesthetic medicines is another key factor to drive growth for aesthetic medicines market
Aesthetic Medicine Market – Segmentation
The aesthetic medicine market can be bifurcated on the basis of: route of administration, application, and region
In terms of route of administration, the aesthetic medicine market can be divided into:
Based on application, the aesthetic medicine market can be fragmented into:
- Skin rejuvenation
- Wrinkle filling
- Volume lifting
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.